BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10825007)

  • 1. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma.
    Gordon AT; Brinkschmidt C; Anderson J; Coleman N; Dockhorn-Dworniczak B; Pritchard-Jones K; Shipley J
    Genes Chromosomes Cancer; 2000 Jun; 28(2):220-6. PubMed ID: 10825007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization.
    Weber-Hall S; Anderson J; McManus A; Abe S; Nojima T; Pinkerton R; Pritchard-Jones K; Shipley J
    Cancer Res; 1996 Jul; 56(14):3220-4. PubMed ID: 8764111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
    Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
    Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction.
    Anderson J; Renshaw J; McManus A; Carter R; Mitchell C; Adams S; Pritchard-Jones K
    Am J Pathol; 1997 Feb; 150(2):477-82. PubMed ID: 9033264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma using the reverse transcriptase-polymerase chain reaction.
    Arden KC; Anderson MJ; Finckenstein FG; Czekay S; Cavenee WK
    Genes Chromosomes Cancer; 1996 Aug; 16(4):254-60. PubMed ID: 8875239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid variant of alveolar rhabdomyosarcoma with unbalanced t(2;13) and hypotetraploidy, without MYCN amplification.
    Smith A; Sharma P; Tomlinson J; Robson L; Goldrick A
    Pathology; 2001 Feb; 33(1):108-11. PubMed ID: 11280599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14).
    Meddeb M; Valent A; Danglot G; Nguyen VC; Duverger A; Fouquet F; Terrier-Lacombe MJ; Oberlin O; Bernheim A
    Cytogenet Cell Genet; 1996; 73(4):325-30. PubMed ID: 8751388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
    Heidenblad M; Hallor KH; Staaf J; Jönsson G; Borg A; Höglund M; Mertens F; Mandahl N
    Oncogene; 2006 Nov; 25(53):7106-16. PubMed ID: 16732325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes, chromosomes, and rhabdomyosarcoma.
    Anderson J; Gordon A; Pritchard-Jones K; Shipley J
    Genes Chromosomes Cancer; 1999 Dec; 26(4):275-85. PubMed ID: 10534762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.
    Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M
    Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
    Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
    Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
    Barr FG; Duan F; Smith LM; Gustafson D; Pitts M; Hammond S; Gastier-Foster JM
    Genes Chromosomes Cancer; 2009 Aug; 48(8):661-72. PubMed ID: 19422036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene alterations and apoptosis in rhabdomyosarcoma.
    Boman F; Brel D; Antunes L; Alhamany Z; Floquet J; Boccon-Gibod L
    Pediatr Pathol Lab Med; 1997; 17(2):233-47. PubMed ID: 9086530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype.
    Williamson D; Lu YJ; Gordon T; Sciot R; Kelsey A; Fisher C; Poremba C; Anderson J; Pritchard-Jones K; Shipley J
    J Clin Oncol; 2005 Feb; 23(4):880-8. PubMed ID: 15681534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.
    Lillington DM; Kingston JE; Coen PG; Price E; Hungerford J; Domizio P; Young BD; Onadim Z
    Genes Chromosomes Cancer; 2003 Feb; 36(2):121-8. PubMed ID: 12508240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.
    Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A
    J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma--a diagnostic tool in minimally invasive biopsies.
    McManus AP; O'Reilly MA; Jones KP; Gusterson BA; Mitchell CD; Pinkerton CR; Shipley JM
    J Pathol; 1996 Apr; 178(4):410-4. PubMed ID: 8691319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposed explanation for female predominance in alveolar soft part sarcoma. Noninactivation of X; autosome translocation fusion gene?
    Bu X; Bernstein L
    Cancer; 2005 Mar; 103(6):1245-53. PubMed ID: 15693033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.